Search
Arrivent Biopharma Inc
AVBPAdd to Watchlist
29.820USD
-0.840-2.74%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.39BMarket Cap
LossP/E TTM
AVBP Financials
See Arrivent Biopharma Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Arrivent Biopharma Inc Earnings Date
Latest Release
May 11, 2026
EPS / Forecast
-0.96/-0.89
Revenue / Forecast
--/0.00
Period
FY2025 Earnings
Revenue(YoY)
--
--
EPS(YoY)
-4.32
-69.06%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What are the current assets of Arrivent Biopharma Inc?
According to Arrivent Biopharma Inc's FY2025 earnings report, its current assets were 332.90M, with a year-on-year change of 46.66.
What are the total assets of Arrivent Biopharma Inc?
According to Arrivent Biopharma Inc's FY2025 earnings report, its total assets of Arrivent Biopharma Inc were 333.17M, with a year-on-year change of 21.18.
What are the total liabilities of Arrivent Biopharma Inc?
According to Arrivent Biopharma Inc's FY2025 earnings report, its total liabilities of Arrivent Biopharma Inc were 25.95M, with a year-on-year change of 50.08.
What is the total equity of Arrivent Biopharma Inc?
According to Arrivent Biopharma Inc's FY2025 earnings report, its total equity of Arrivent Biopharma Inc was 307.22M, with a year-on-year change of 19.24.
What is the net operating income of Arrivent Biopharma Inc?
According to Arrivent Biopharma Inc's FY2025 earnings report, its net operating income of Arrivent Biopharma Inc was -177.53M, with a year-on-year change of -88.25.
What is the net investment of Arrivent Biopharma Inc?
According to Arrivent Biopharma Inc's FY2025 earnings report, its net investment of Arrivent Biopharma Inc was -71.23M, with a year-on-year change of 62.99.
What is the net financing of Arrivent Biopharma Inc?
According to Arrivent Biopharma Inc's FY2025 earnings report, its net financing of Arrivent Biopharma Inc was 203.06M, with a year-on-year change of 8.83.
What is the Earnings Per Share (EPS) of Arrivent Biopharma Inc?
According to Arrivent Biopharma Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -4.32, with a year-on-year change of -69.06.
What is the net income of Arrivent Biopharma Inc?
According to Arrivent Biopharma Inc's FY2025 earnings report, its net income was -166.31M, with a year-on-year change of -106.62.
What is the Return on Equity (ROE) of Arrivent Biopharma Inc?
According to Arrivent Biopharma Inc's FY2025 earnings report, its Return on Equity (ROE) was -58.88, with a year-on-year change of 61.79.
What is the Return on Assets (ROA) of Arrivent Biopharma Inc?
According to Arrivent Biopharma Inc's FY2025 earnings report, its Return on Assets (ROA) was -54.70, with a year-on-year change of -48.84.
What is the operating profit of Arrivent Biopharma Inc?
According to Arrivent Biopharma Inc's FY2025 earnings report, its operating profit was -177.53M, with a year-on-year change of -88.25.